- Report on postmarketing surveillance of vaccines in the Emilia-Romagna region from 2012 to 2013
- Vaccine Report 2009-2010 - Postmarketing surveillance in Italy
- Vaccine Report 2011 - Postmarketing surveillance in Italy
- Vaccine Report 2012 - Postmarketing surveillance in Italy
- Vaccine Report 2013 - Postmarketing surveillance in Italy
- Vaccine Report 2014-2015 - Postmarketing surveillance in Italy
- Vaccine Report 2016 - Postmarketing surveillance in Italy
- Vaccine Report 2017 - Postmarketing surveillance in Italy
- Vaccine Report 2018 - Postmarketing surveillance in Italy
- Vaccine Report 2019 - Postmarketing surveillance in Italy
- Vaccine Report 2020 - Postmarketing surveillance in Italy
- Vaccine Report 2021 - Postmarketing surveillance in Italy
- Puglia region. Surveillance of adverse vaccine events in Puglia. 2013/2017 report
- Surveillance of adverse events to vaccines administered at 0-17 years of age reported in Emilia-Romagna period 2006-2009
- Surveillance of adverse events to vaccines administered in adulthood reported in Emilia-Romagna year 2010
- MPVR vaccine study in Puglia: adverse events for 4 out of 100 children
IMPORTANT NOTE: Corvelva invites you to get in-depth information by reading all the sections and links, as well as the manufacturer's product leaflets and technical data sheets, and to speak with one or more trusted professionals before deciding to vaccinate yourself or your child. This information is for informational purposes only and is not intended as medical advice.